Amid uncertain future, California’s stem cell agency loses transformative leader

C. Randal Mills, president and CEO of the California Institute for Regenerative Medicine, briefly recaps progress the state agency has made since 2014 in getting stem cell therapies into clinical trials. Taken on July 21, 2016, at the Sanford Consortium for Regenerative Medicine in La Jolla.


Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )


Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.